492-22-8
CAS 492-22-8
492-22-8 (CAS 492-22-8) is a pharmaceutical compound with 3 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | GI50 | 98557.51881355933 nM | 59 | - |
| - | Potency | 29846.957142857143 nM | 7 | - |
| - | IC50 | 43566.666666666664 nM | 3 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is 492-22-8 used for in pharmaceutical contexts?
492-22-8 (CAS 492-22-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for 492-22-8?
No adverse-event association or SIDER side-effect rows are rendered for 492-22-8 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is 492-22-8 also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Thioxanthone with EU status "permitted".
What clinical phase is 492-22-8 in?
No phase 1-4 clinical development badge is rendered for 492-22-8 because the matched compound identifier rows do not contain a max-phase value.